Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19576 AL 19590

The Alzheimer's disease mitochondrial cascade hypothesis

Swerdlow RH, Burns JM, Khan SM.

J Alzheimers Dis. 2010;20 Suppl 2(Suppl 2):S265-79. doi: 10.3233/JAD-2010-100339.

[Melatonin and Alzheimer's disease]

Arushanian EB.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(1):100-6.

Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Shima K, Kuhlenbäumer G, Rupp J.

Med Microbiol Immunol. 2010 Nov;199(4):283-9. doi: 10.1007/s00430-010-0162-1. Epub 2010 May 6.

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

Neurobiol Aging. 2010 Aug;31(8):1375-85. doi: 10.1016/j.neurobiolaging.2010.01.022. Epub 2010 May 5.

Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks

de Mendonça A, Cunha RA.

J Alzheimers Dis. 2010;20 Suppl 1:S249-52. doi: 10.3233/JAD-2010-01411.

Targeting tau protein in Alzheimer's disease

Gong CX, Grundke-Iqbal I, Iqbal K.

Drugs Aging. 2010 May;27(5):351-65. doi: 10.2165/11536110-000000000-00000.

Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes

Mori I.

J Neurovirol. 2010 May;16(3):203-7. doi: 10.3109/13550281003739040.

Cholesterol, Alzheimer's disease, prion disorders: a ménage à trois?

Pani A, Mandas A, Dessì S.

Curr Drug Targets. 2010 Aug;11(8):1018-31. doi: 10.2174/138945010791591386.

Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications

Lahiri DK, Maloney B.

Exp Neurol. 2010 Sep;225(1):51-4. doi: 10.1016/j.expneurol.2010.04.018. Epub 2010 May 5.

Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis

Haughey NJ, Bandaru VV, Bae M, Mattson MP.

Biochim Biophys Acta. 2010 Aug;1801(8):878-86. doi: 10.1016/j.bbalip.2010.05.003. Epub 2010 May 7.

Comparison of manual and automated determination of hippocampal volumes in MCI and early AD

Shen L, Saykin AJ, Kim S, Firpi HA, West JD, Risacher SL, McDonald BC, McHugh TL, Wishart HA, Flashman LA.

Brain Imaging Behav. 2010 Mar;4(1):86-95. doi: 10.1007/s11682-010-9088-x.

Established donepezil treatment modulates task relevant regional brain activation in early Alzheimer's disease

McGeown WJ, Shanks MF, Forbes-McKay KE, Waiter GD, Elrick I, Venneri MG, Venneri A.

Curr Alzheimer Res. 2010 Aug;7(5):415-27. doi: 10.2174/156720510791383877.

Transdermal rivastigmine for Alzheimer's disease: skin deep or scratching the surface?

Larner AJ.

Int J Clin Pract. 2010 Apr;64(5):534-6. doi: 10.1111/j.1742-1241.2009.02305.x.

An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease

Roses AD.

Arch Neurol. 2010 May;67(5):536-41. doi: 10.1001/archneurol.2010.88.

Genome-wide analysis of genetic loci associated with Alzheimer disease

Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT Jr, Janssens AC, Pankratz VS, Dartigues JF, Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, Harris TB, Petersen RC, Berr C, Owen MJ, Lopez-Arrieta J, Varadarajan BN, Becker JT, Rivadeneira F, Nalls MA, Graff-Radford NR, Campion D, Auerbach S, Rice K, Hofman A, Jonsson PV, Schmidt H, Lathrop M, Mosley TH, Au R, Psaty BM, Uitterlinden AG, Farrer LA, Lumley T, Ruiz A, Williams J, Amouyel P, Younkin SG, Wolf PA, Launer LJ, Lopez OL, van Duijn CM, Breteler MM; CHARGE Consortium; GERAD1 Consortium; EADI1 Consortium.

JAMA. 2010 May 12;303(18):1832-40. doi: 10.1001/jama.2010.574.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias